Key challenges in the current management of syncope

Nature Reviews Cardiology

Volumn 9, Issue 10, 2012, Pages 590-598

  Sutton, Richard ^a   Brignole, Michele ^b   Benditt, David G ^c  

^a ICCH Building ^*  (United Kingdom)

^b DEPARTMENT OF CARDIOLOGY   (Italy)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATENOLOL; DISOPYRAMIDE; FLUDROCORTISONE; METHYLPHENIDATE; METOPROLOL; MIDODRINE; SCOPOLAMINE; THEOPHYLLINE;

COOPERATION; COST CONTROL; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; ELECTROCARDIOGRAM; FAINTNESS; HEART PACING; HUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYMPTOM; TILT TABLE TEST; UNCONSCIOUSNESS;

BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; RISK ASSESSMENT; SYNCOPE; TILT-TABLE TEST; TIME FACTORS; TRIAGE;

EID: 84866740181     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2012.102     Document Type: Review

References (71)

1. The Task Force for the Diagnosis and Management of Syncope et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur. Heart J. 30, 2631-2671 (2009).
2. van Dijk, J. G., Thijs, R. D., Benditt, D. G. & Wieling, W. A guide to disorders causing transient loss of consciousness: focus on syncope. Nat. Rev. Neurol. 5, 438-448 (2009).
3. Sun, B. C., Emond, J. A. & Camargo, C. A. Jr. Direct medical costs of syncope-related hospitalizations in the United States. Am. J. Cardiol. 95, 668-671 (2005).
4. Malasana, G., Brignole, M., Daccarett, M., Sherwood, R. & Hamdan, M. H. The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin. Electrophysiol. 34, 278-283 (2011).
5. Disertori, M. et al. Management of syncope referred for emergency to general hospitals. Europace 5, 283-291 (2003).
6. Brignole, M. et al. Prospective multicentre systematic guideline-based management of patients referred to the syncope units of general hospitals. Europace 12, 109-118 (2010).
7. Shen, W. K. et al. Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation 110, 3636-3645 (2004).
8. Youde, J., Ruse, C., Parker, S. & Fotherby, M. A high diagnostic rate in older patients attending an integrated syncope clinic. J. Am. Geriatr. Soc. 48, 783-787 (2000).
9. Petkar, S. et al. Initial experience with a rapid access blackouts triage clinic. Clin. Med. 11, 11-16 (2011).
10. Ziadi, A., Clough, P., Cooper, P., Scheepers, B. & Fitzpatrick, A. P. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J. Am. Coll. Cardiol. 36, 181-184 (2000).
11. Kouakam, C. et al. Long-term follow-up of children and adolescents with syncope: predictor of syncope recurrence. Eur. Heart J. 22, 1618-1625 (2001).
12. Benbadis, S. R. & Chichkova, R. Psychogenic pseudosyncope: an underestimated and provable diagnosis. Epilepsy Behav. 9, 106-110 (2006).
13. Plug, L. & Reuber, M. Making the diagnosis in patients with blackouts: it's all in the history. Pract. Neurol. 9, 4-15 (2009).
14. Hall-Patch, L. et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia 51, 70-78 (2010).
15. Grubb, B. P. et al. Syncope and seizures of psychogenic origin: identification with head-upright tilt table testing. Clin. Cardiol. 15, 839-842 (1992).
16. Bodde, N. M. G. et al. Psychogenic non-epileptic seizures-diagnostic issues: a critical review. Clin. Neurol. Neurosurg. 111, 1-9 (2009).
17. Colivicchi, F. et al. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur. Heart J. 24, 811-819 (2003).
18. Quinn, J. V. et al. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann. Emerg. Med. 43, 224-232 (2004).
19. Costantino, G. et al. Short-and long-term prognosis of syncope, risk factors, and role of hospital admission: results from the STePS (Short-Term Prognosis of Syncope) study. J. Am. Coll. Cardiol. 51, 276-283 (2008).
20. Reed, M. J. et al. The ROSE (Risk Stratification of Syncope in the Emergency Department) study. J. Am. Coll. Cardiol. 55, 713-721 (2010).
21. Grossman, S. A. et al. Predicting adverse outcomes in syncope. J. Emerg. Med. 33, 233-239 (2007).
22. Serrano, L. A. et al. Accuracy and quality of clinical decision rules for syncope in the emergency department: a systematic review and meta-analysis. Ann. Emerg. Med. 56, 362-373.e1 (2010).
23. Thiruganasambandamoorthy, V. et al. External validation of the San Francisco Syncope Rule in the Canadian setting. Ann. Emerg. Med. 55, 464-472 (2010).
24. Reed, M. J., Henderson, S. S., Newby, D. E. & Gray, A. J. One-year prognosis after syncope and the failure of the ROSE decision instrument to predict one-year adverse events. Ann. Emerg. Med. 58, 250-256 (2011).
25. Grossman, S. A. et al. Can benign etiologies predict benign outcomes in high-risk syncope patients? J. Emerg. Med. 40, 592-597 (2011).
26. Sheldon, R. S. et al. Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can. J. Cardiol. 27, 246-253 (2011).
27. Bartoletti, A. et al. Hospital admission of patients referred to the Emergency Department for syncope: a single-hospital prospective study based on the application of the European Society of Cardiology guidelines on syncope. Eur. Heart J. 27, 83-88 (2006).
28. McCarthy, F. et al. Resource utilization for syncope presenting to an acute hospital Emergency Department. Ir. J. Med. Sci. 179, 551-555 (2010).
29. Benditt, D. G. & Can, I. Initial evaluation of 'syncope and collapse': the need for a risk stratification consensus. J. Am. Coll. Cardiol. 55, 722-724 (2010).
30. Moya, A. et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur. Heart J. 32, 1535-1541 (2011).
31. Martin, T. P., Hanusa, B. H. & Kapoor, W. N. Risk stratification of patients with syncope. Ann. Emerg. Med. 29, 459-466 (1997).
32. Brignole, M. et al. Standardized-care pathway vs usual management of syncope patients presenting as emergencies at general hospitals. Europace 8, 644-650 (2006).
33. Brignole, M. et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur. Heart J. 27, 76-82 (2006).
34. Daccarett, M., Jetter, T. L., Wasmund, S. L., Brignole, M. & Hamdan, M. Syncope in the emergency department: comparison of standardized admission criteria with clinical practice. Europace 13, 1632-1638 (2011).
35. Rothman, S. A. et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J. Cardiovasc. Electrophysiol. 18, 241-247 (2007).
36. Krahn, A. D., Klein, G. J., Yee, R. & Skanes, A. C. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104, 46-51 (2001).
37. Farwell, D. J., Freemantle, N. & Sulke, A. N. Use of implantable loop recorders in the diagnosis and management of syncope. Eur. Heart J. 25, 1257-1263 (2004).
38. National Institute for Health and Clinical Excellence. Transient loss of consciousness in adults and young people (CG109) [online], http://www.nice.org. uk/guidance/CG109 (2010).
39. Edvardsson, N. et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace 13, 262-269 (2011).
40. Furukawa, T. et al. Effectiveness of remote monitoring in the management of syncope and palpitations. Europace 13, 431-437 (2011).
41. Hong, P. S., Veasey, R. A. & Sulke, N. All is not lost: utilizing continuous remote ILR monitoring to diagnose syncope. Pacing Clin. Electrophysiol. 33, 763-765 (2010).
42. Arrocha, A., Klein, G. J., Benditt, D. G., Sutton, R. & Krahn, A. D. Remote electrocardiographic monitoring with a wireless implantable loop recorder: minimizing the data review burden. Pacing Clin. Electrophysiol. 33, 1347-1352 (2010).
43. Brignole, M. et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur. Heart J. 27, 1085-1092 (2006).
44. Furukawa, T., Maggi, R., Bertolone, C., Fontana, D. & Brignole, M. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J. Cardiovasc. Electrophysiol. 23, 67-71 (2012).
45. Davis, S., Westby, M., Pitcher, D. & Petkar, S. Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained. Europace 14, 402-409 (2012).
46. Flammang, D., Church, T., Waynberger, M., Chassing, A. & Antiel, M. Can adenosine 5'-triphosphate be used to select treatment in severe vasovagal syndrome? Circulation 96, 1201-1208 (1997).
47. Flammang, D. et al. Contribution of head-up tilt testing and ATP testing in assessing the mechanisms of vasovagal syndrome: preliminary results and potential therapeutic implications. Circulation 99, 2427-2433 (1999).
48. Brignole, M. et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J. Am. Coll. Cardiol. 58, 167-173 (2011).
49. Flammang, D. et al. Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation 125, 31-36 (2012).
50. Romme, J. J. C. M. et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. Cochrane Database of Systematic Reviews, Issue 10. Art. No.: CD004194. http://dx.doi.org/10.1002/14651858.CD004194.pub3 (2011).
51. Sheldon, R. et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113, 1164-1170 (2006).
52. Raj, S. R., Rose, S., Ritchie, D., Sheldon, R. S. & the POST II Investigators. The Second Prevention of Syncope Trial (POST II)-A randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am. Heart J. 151, 1186.e11-17 (2006).
53. Raviele, A. et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99, 1452-1457 (1999).
54. Ward, C. R., Gray, J. C., Gilroy, J. J. & Kenny, R. A. Midodrine: a role in the management of neurocardiogenic syncope. Heart 79, 45-49 (1998).
55. Perez-Lugones, A. et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J. Cardiovasc. Electrophysiol. 12, 935-938 (2001).
56. Kaufmann, H., Saadia, D. & Voustianiouk, A. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann. Neurol. 52, 342-345 (2002).
57. Romme, J. J. C. M., van Dijk, N., Go-Schön, I. K., Reitsma, J. B. & Wieling, W. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace 13, 1639-1647 (2011).
58. US Department of Health & Human Sciences (US FDA). Midodrine update: opening of a public docket. (FDA-2010-N-0637) [online], http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm239456.htm (2011).
59. Di Girolamo, E. et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo controlled study. J. Am. Coll. Cardiol. 33, 1227-1230 (1999).
60. Theodorakis, G. N. et al. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 8, 193-198 (2006).
61. Takata, T. S. et al. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106, 1500-1504 (2002).
62. Brignole, M. et al. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur. Heart J. 27, 2232-2239 (2006).
63. Connolly, S. J., Sheldon, R., Roberts, R. S. & Gent, M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J. Am. Coll. Cardiol. 33, 16-20 (1999).
64. Sutton, R. et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 102, 294-299 (2000).
65. Ammirati, F., Colivicchi, F., Santini, M. & the Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104, 52-57 (2001).
66. Connolly, S. J. et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 289, 2224-2229 (2003).
67. Raviele, A. et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur. Heart J. 25, 1741-1748 (2004).
68. Brignole, M. et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized study. Circulation 125, 2566-2571 (2012).
69. Pachon, J. C. et al. "Cardioneuroablation"-new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace 7, 1-13 (2005).
70. Pachon, J. C. et al. Catheter ablation of severe neurally mediated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace 13, 1231-1242 (2011).
71. Yao, Y. et al. Endocardial autonomic denervation of the left atrium to treat vasovagal syncope: an early experience in humans. Circ. Arrhythm. Electrophysiol. 5, 279-286 (2012).